Evidence map›Paper›PMID 40800151›Full record

ArticleHealth SA = SA Gesondheid2025

A substance use relapse prevention programme for youth with substance use problems in Botswana.

Wada Gaolaolwe, Miriam M Moagi, Gaotswake P Kovane, Leepile A Sehularo

Abstract read
In one paragraph

Article in Health SA = SA Gesondheid, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Wada GaolaolweNuMIQ Research Focus Area, Faculty of Health Sciences, North-West University, Mahikeng, South Africa.ORCID https://orcid.org/0000-0003-1014-2005
Miriam M MoagiDepartment of Nursing, Faculty of Health Sciences, University of Limpopo, Limpopo, South Africa.ORCID https://orcid.org/0000-0001-7291-1418
Gaotswake P KovaneNuMIQ Research Focus Area, Faculty of Health Sciences, North-West University, Mahikeng, South Africa.ORCID https://orcid.org/0000-0002-3672-8736
Leepile A SehularoLifestyle Diseases Research Focus Area, Faculty of Health Sciences, North-West University, Mahikeng, South Africa.ORCID https://orcid.org/0000-0003-4286-6761

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Substance use relapse among the youth is a worldwide concern with negative ramifications on their lives, families, communities and nations at large. Aim: The purpose of this study was to develop and validate a programme for the prevention of substance use relapse among youth with substance use problems in Lobatse, Botswana. Setting: The research was conducted at a referral psychiatric hospital in Lobatse, Botswana. Methods: A multiphase approach was used, which included an integrative literature review in phase one and two qualitative studies (exploratory, descriptive and contextual design) in the empirical phase. The survey list of the practice-oriented theory was used for concept classification and guided the programme's development. Results: The findings from the studies indicate that the programme for preventing substance use relapse among youth should focus more on aftercare initiatives such as tracking and assessment of those under this programme. Conclusion: A substance use relapse prevention programme for the youth should entail and provide impetus on the aftercare of the youth substance users to prevent their relapses. Contribution: The programme provides a robust strategy for preventing substance use relapse with actionable approaches for mental health professionals to effectively address the unique needs and circumstances of youth substance users through ongoing support and active engagement in recovery activities.

Indexed as

addictionaftercarepreventionprogrammerecoveryrelapsesubstance useyouth

Identifiers

PMID40800151
PMCPMC12339760

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.